Skip to main content

D-Dimer HS

BRD ID: 2023
Tier: SOP
Source: TCP Project
Document: BARC PRO 014 D-Dimer.pdf[Size: 3387.68 KB]
Number of times downloaded: 1499

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to measure quantify levels of D-dimer, a product of clot degradation, in plasma by the latex agglutination method as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).